review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.PHRS.2016.07.006 |
P698 | PubMed publication ID | 27394168 |
P50 | author | Raymond M. Schiffelers | Q39472386 |
Riccardo Vago | Q55712274 | ||
P2093 | author name string | Sander A A Kooijmans | |
Natasa Zarovni | |||
P2860 | cites work | MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer | Q29614237 |
Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor | Q36043818 | ||
P921 | main subject | extracellular vesicle | Q21097485 |
P304 | page(s) | 487-500 | |
P577 | publication date | 2016-07-06 | |
P1433 | published in | Pharmacological Research | Q15724622 |
P1476 | title | Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment | |
P478 | volume | 111 |
Q91811850 | Advances on Non-Genetic Cell Membrane Engineering for Biomedical Applications |
Q44298061 | Challenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies |
Q91899409 | Circulating miRNome detection analysis reveals 537 miRNAS in plasma, 625 in extracellular vesicles and a discriminant plasma signature of 19 miRNAs in children with retinoblastoma from which 14 are also detected in corresponding primary tumors |
Q46311969 | Engineering of extracellular vesicles as drug delivery vehicles |
Q64104933 | Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency |
Q59792870 | Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo |
Q64389196 | Exosome-packaged miR-1246 contributes to bystander DNA damage by targeting LIG4 |
Q92798173 | Exosomes as Therapeutic Vehicles for Cancer |
Q61812111 | Exosomes: A Promising Avenue for the Diagnosis of Breast Cancer |
Q64086552 | Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking |
Q89739035 | Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo |
Q92924422 | Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Renal Diseases |
Q90459409 | Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives |
Q64097130 | Mesenchymal stem cell exosomes: a two-edged sword in cancer therapy |
Q41918293 | Plant Ribosome-Inactivating Proteins: Progesses, Challenges and Biotechnological Applications (and a Few Digressions). |
Q99238314 | Recent Advances in the Use of Exosomes in Sjögren's Syndrome |
Q89976335 | Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications |
Q91828311 | Review of the Application of Nanovesicles and the Human Interstitial Fluid in Gastrointestinal Premalignant Lesion Detection, Diagnosis, Prognosis and Therapy |
Q33899251 | Secretome of in vitro cultured human embryos contains extracellular vesicles that are uptaken by the maternal side. |
Q90721850 | Stem Cell-Derived Extracellular Vesicles and Kidney Regeneration |
Q64103462 | Stem Cell-Derived Extracellular Vesicles as Immunomodulatory Therapeutics |
Q28075450 | Towards Therapeutic Delivery of Extracellular Vesicles: Strategies for In Vivo Tracking and Biodistribution Analysis |
Q99720308 | Tumor-derived microparticles in tumor immunology and immunotherapy |